FR3124082B1 - Utilisation de la zerumbone pour un traitement cosmétique - Google Patents
Utilisation de la zerumbone pour un traitement cosmétique Download PDFInfo
- Publication number
- FR3124082B1 FR3124082B1 FR2106601A FR2106601A FR3124082B1 FR 3124082 B1 FR3124082 B1 FR 3124082B1 FR 2106601 A FR2106601 A FR 2106601A FR 2106601 A FR2106601 A FR 2106601A FR 3124082 B1 FR3124082 B1 FR 3124082B1
- Authority
- FR
- France
- Prior art keywords
- zerumbone
- erk
- plant extract
- extract containing
- cosmetic treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VDFOMVRWDSKWSL-UHFFFAOYSA-N Zerumbone Natural products CC1=C2CC(C)(C)C=C2C(=O)C(=CCC1)C VDFOMVRWDSKWSL-UHFFFAOYSA-N 0.000 title abstract 3
- GIHNTRQPEMKFKO-SKTNYSRSSA-N zerumbone Chemical compound C\C1=C/CC(C)(C)\C=C\C(=O)\C(C)=C\CC1 GIHNTRQPEMKFKO-SKTNYSRSSA-N 0.000 title abstract 3
- GIHNTRQPEMKFKO-UHFFFAOYSA-N zurembone Natural products CC1=CCC(C)(C)C=CC(=O)C(C)=CCC1 GIHNTRQPEMKFKO-UHFFFAOYSA-N 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 title 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
- 239000000419 plant extract Substances 0.000 abstract 2
- 108700027649 Mitogen-Activated Protein Kinase 3 Proteins 0.000 abstract 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 abstract 1
- 108700015928 Mitogen-activated protein kinase 13 Proteins 0.000 abstract 1
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 abstract 1
- 108091008611 Protein Kinase B Proteins 0.000 abstract 1
- 102000003425 Tyrosinase Human genes 0.000 abstract 1
- 108060008724 Tyrosinase Proteins 0.000 abstract 1
- 241000234299 Zingiberaceae Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
- 229960002986 dinoprostone Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 abstract 1
- 210000002780 melanosome Anatomy 0.000 abstract 1
- 230000037353 metabolic pathway Effects 0.000 abstract 1
- 230000026731 phosphorylation Effects 0.000 abstract 1
- 238000006366 phosphorylation reaction Methods 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Selon l’invention, la zerumbone, ou un dérivé et/ou analogue ou extrait de plante en contenant, est utilisé pour un traitement des zones hyperpigmentées de la peau (pour en empêcher l’apparition et/ou les traiter une fois présentes pour les estomper et/ou les faire disparaitre), grâce à la phosphorylation de voies métaboliques Akt, ERK-1 et ERK-2 et la diminution de la synthèse de PGE2, influençant sur l’activité tyrosinase et la mélanine, ainsi que son transfert du mélanosome aux kératinocytes. La zerumbone ou l’extrait de plante en contenant est issu(e) de la famille des Zingiberacées et l’extraction est réalisée à l’aide d’un fluide supercritique.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2106601A FR3124082B1 (fr) | 2021-06-22 | 2021-06-22 | Utilisation de la zerumbone pour un traitement cosmétique |
| PCT/EP2022/066480 WO2022268643A1 (fr) | 2021-06-22 | 2022-06-16 | Utilisation de zérumbone pour traitement esthétique |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2106601A FR3124082B1 (fr) | 2021-06-22 | 2021-06-22 | Utilisation de la zerumbone pour un traitement cosmétique |
| FR2106601 | 2021-06-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3124082A1 FR3124082A1 (fr) | 2022-12-23 |
| FR3124082B1 true FR3124082B1 (fr) | 2023-11-24 |
Family
ID=77317115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR2106601A Active FR3124082B1 (fr) | 2021-06-22 | 2021-06-22 | Utilisation de la zerumbone pour un traitement cosmétique |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR3124082B1 (fr) |
| WO (1) | WO2022268643A1 (fr) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10330243A (ja) * | 1997-05-30 | 1998-12-15 | Nonogawa Shoji Kk | 美白化粧料 |
| JP2000159626A (ja) * | 1998-12-01 | 2000-06-13 | Shiseido Co Ltd | 皮膚外用剤 |
| US7588788B2 (en) | 2004-07-23 | 2009-09-15 | Wholesome Life Science Co., Ltd. | Immune modulation and anti-allergy activities of Zingiber zerumbet |
| FR2985425A1 (fr) | 2012-01-10 | 2013-07-12 | Sederma Sa | Nouvelle utilisation de la zerumbone |
| FR2985424B1 (fr) * | 2012-01-10 | 2019-03-29 | Sederma | Nouvelle utilisation topique de la zerumbone |
| FR2998570B1 (fr) | 2012-11-26 | 2016-12-02 | Sederma Sa | Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes |
| KR20150057765A (ko) * | 2013-11-20 | 2015-05-28 | 주식회사 엘지생활건강 | 한방향 유효성분 트랜스-캐리오필렌(trans-caryophyllene)을 피부 유용성분으로 함유하는 화장료 조성물 |
| FR3021319B1 (fr) | 2014-05-22 | 2018-08-31 | Sederma | Peptides, compositions les comprenant et utilisations notamment cosmetiques |
| FR3029782B1 (fr) | 2014-12-16 | 2019-06-07 | Sederma | Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques |
| KR20180023504A (ko) * | 2016-08-26 | 2018-03-07 | 건국대학교 글로컬산학협력단 | 제럼본을 함유하는 피부 미백용 조성물 |
-
2021
- 2021-06-22 FR FR2106601A patent/FR3124082B1/fr active Active
-
2022
- 2022-06-16 WO PCT/EP2022/066480 patent/WO2022268643A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| FR3124082A1 (fr) | 2022-12-23 |
| WO2022268643A1 (fr) | 2022-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tagne et al. | Anticancer and antioxidant activities of methanol extracts and fractions of some Cameroonian medicinal plants | |
| Mayouf et al. | Antioxidant and anti-inflammatory effect of Asphodelus microcarpus methanolic extracts | |
| MX2021010544A (es) | Inhibidores de la proteina tirosina fosfatasa y metodos para usarlos. | |
| CR20210017A (es) | Inhibidores de proteína tirosina fosfatosa y sus métodos de uso | |
| FR3124082B1 (fr) | Utilisation de la zerumbone pour un traitement cosmétique | |
| Moradi et al. | Quorum-quenching activity of some Iranian medicinal plants | |
| BR112022006361A2 (pt) | Composição inovadora para cuidados com a pele | |
| BR112022006345A2 (pt) | Composição inovadora para cuidados com a pele | |
| BR112022006342A2 (pt) | Composição inovadora de cuidados com a pele | |
| Karadeniz et al. | Inhibition of MMP-2 and MMP-9 activities by solvent-partitioned Sargassum horneri extracts | |
| Hong et al. | Clinical efficacy of external application containing Betula platyphyllae Cortex, Viticis fructus, Agrimoniae herba in atopic dermatitis | |
| CN108379147A (zh) | 酵素营养洗发水 | |
| ATE406158T1 (de) | Verwendung von vitamin c zur behandlung der charcot-marie-tooth krankheit | |
| Uddin et al. | Thrombolytic activities of Spilanthes calva and Leucas zeylanica | |
| Durbin et al. | The role of Allicin in the resistance of Garlic to Penicillium spp. | |
| FR3089974B1 (fr) | Nouveaux composés dépigmentants extraits de Eryngium maritimum | |
| Пласконіс et al. | ERUCA SATIVA IS A PROMISING PLANT FOR USE IN PHARMACY | |
| AU2020267270A1 (en) | Skin cancer cure medicine use natural material extraction or synthesized ingredients or modified synthesized ingredients of this natural material extraction. | |
| AL-DALLEE et al. | Ethanol Extract of Cordia myxa L Fruit Increase Expression of Antioxidant Enzymes and Tumor Suppressor PTEN Genes in MCF-7 Breast Cancer Cells | |
| TR202012040A2 (tr) | Türkiye' de yetişen kızılçam bitkisinden oligomerik proantosiyanidinlerin ve komplekslerinin (oligomeric proanthocyanidin complexes; opc) eldesi | |
| MX2021000496A (es) | Formulacion herbolaria para tratamiento topico de enfermedades de la piel. | |
| Delgado et al. | Back to basics with tutti foodie | |
| Park et al. | Comparative study of protocorm-like body and multiple shoots from Dendrobium Candidum on biological activities | |
| US20150231061A1 (en) | Use of spider venoms for skin whitening/depigmenting and composition comprising spider venoms molecules or synthetic analogs | |
| PL443004A1 (pl) | Ekstrakt z kwiatów, liści i/lub torebek nasiennych niecierpka (Impatiens) oraz liści pandanu (Pandanus), w postaci suchej i płynnej, sposób jego otrzymywania i jego zastosowanie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20221223 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |